CHMP recommends two drugs in May
One drug to diagnose prostate cancer and one to treat epileptic seizures are all the EMA’s expert committee has nominated for full approval during its meeting this month.
by christopher due karlsson, translated by daniel pedersen
During this month’s meeting of the European Medicines Agency’s (EMA) Committee for Medicinal Products for Human Use (CHMP), two new drugs have been nominated for approval.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
